The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed with Intraductal Papilloma without Atypia or Flat Epithelial Atypia by Core Needle Biopsy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: intraductal papilloma without atypia | flat epithelia atypia | Adjacent Synchronous Ipsilateral Infiltrating Carcinoma | Intraductal Papilloma
  • Age: Between 18 - 100 Years
  • Gender: Female

Inclusion Criteria
Must have an imaging abnormality that necessitated a core needle biopsy
Patients must be registered on study within 60 days after core needle biopsy
Exclusion Criteria
Personal history and/or concomitant diagnosis of invasive breast cancer or DCIS
Palpable abnormality diagnosed by core needle biopsy to be FEA or IPWA
Pathologic nipple discharge associated with IPWA
A BIRADS 5 lesion
Discordance between the initial breast imaging finding and the core biopsy pathology report
The presence of atypical ductal hyperplasia on core biopsy
Known current pregnancy
Women who are breastfeeding
Patient registered on study more than 60 days since the date of core needle biopsy

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at or by phone at (888) 264-0005.